Purple Biotech (PPBT) Stock Chart & Stock Price History $2.21 +0.04 (+1.84%) Closing price 04:00 PM EasternExtended Trading$2.17 -0.04 (-1.63%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Purple Biotech Stock Price Performance The Purple Biotech (PPBT) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 52.88%. In the past month, the stock has decreased 11.39%, reflecting recent market activity. As of the latest close, Purple Biotech traded at $2.17 with a market cap of $5.61 million and volume of 30,777 shares. Receive PPBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.25%1 Month Performance-11.39%3 Month Performance-4.74%Year-To-Date Performance-52.88% PPBT Stock Chart for Monday, August, 4, 2025 PPBT Chart by TradingView Purple Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$2.17$2.21+1.84%$2.35$2.1444,664 shs$5.72 million08/01/2025$2.16$2.17+0.46%$2.27$2.0830,777 shs$5.61 million07/31/2025$2.08$2.16+3.85%$2.23$2.0926,386 shs$5.59 million07/30/2025$2.12$2.08-1.89%$2.24$2.0790,830 shs$5.39 million07/29/2025$2.25$2.12-5.78%$2.23$2.11103,095 shs$5.48 million07/28/2025$2.33$2.25-3.43%$2.38$2.2257,994 shs$5.83 million07/25/2025$2.62$2.33-11.07%$2.53$2.23156,077 shs$6.04 million07/24/2025$2.76$2.62-5.07%$2.73$2.474.50 million shs$6.79 million07/23/2025$2.73$2.76+1.10%$2.90$2.64102,823 shs$7.14 million07/22/2025$2.78$2.73-1.80%$2.82$2.6911,383 shs$7.07 million Get the Latest News and Ratings for PPBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$2.60$2.78+6.92%$2.83$2.5779,811 shs$7.20 million07/18/2025$2.53$2.60+2.77%$2.62$2.489,150 shs$6.73 million07/17/2025$2.51$2.53+0.80%$2.60$2.4610,318 shs$6.54 million07/16/2025$2.48$2.51+1.21%$2.53$2.4513,656 shs$6.50 million07/15/2025$2.53$2.48-1.98%$2.54$2.4512,145 shs$6.42 million07/14/2025$2.46$2.53+2.68%$2.54$2.4117,620 shs$6.55 million07/11/2025$2.56$2.46-3.75%$2.54$2.406,419 shs$3.28 million07/10/2025$2.47$2.56+3.64%$2.58$2.3513,197 shs$3.41 million07/09/2025$2.41$2.47+2.49%$2.49$2.365,230 shs$3.29 million07/08/2025$2.44$2.41-1.23%$2.45$2.343,581 shs$3.21 million07/07/2025$2.49$2.44-2.17%$2.51$2.4124,236 shs$3.25 million07/04/2025$2.49$2.49$2.48$2.455,817 shs$3.32 million07/03/2025$2.40$2.49+3.92%$2.48$2.455,817 shs$3.32 million Related Companies Aytu BioPharma Stock Chart Passage Bio Stock Chart Dare Bioscience Stock Chart Lisata Therapeutics Stock Chart Reviva Pharmaceuticals Stock Chart Cadrenal Therapeutics Stock Chart Natural Alternatives International Stock Chart VYNE Therapeutics Stock Chart Elevation Oncology Stock Chart Relmada Therapeutics Stock Chart Receive PPBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PPBT) was last updated on 8/4/2025 by MarketBeat.com Staff From Our Partners[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
